FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072796 [Registered on: 20/08/2024] Trial Registered Prospectively
Last Modified On: 08/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes
Other (Specify) [change in quality of life of patients if an evidence based checklist is used in follow up care]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Use of an evidence based checklist in follow up care of epilepsy patients and its effect on quality of life. 
Scientific Title of Study   Comparing outcomes of epilepsy patient follow-up care with and without a checklist – A randomised control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Vaibhav Bhandari 
Designation  Senior resident 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  7th floor, Department of neurology, Cardiothoracic and Neuroscience Centre, All India Institute of Medical Sciences, New Delhi

South
DELHI
110029
India 
Phone  9930265650  
Fax    
Email  drvaibhavb96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mamta Bhushan Singh 
Designation  professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Department of neurology, Cardiothoracic and Neuroscience Centre, All India Institute of Medical Sciences, New Delhi

South
DELHI
110029
India 
Phone  8929042755  
Fax    
Email  mbsneuro@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mamta Bhushan Singh 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Department of neurology, Cardiothoracic and Neuroscience Centre, All India Institute of Medical Sciences, New Delhi

South
DELHI
110029
India 
Phone  8929042755  
Fax    
Email  mbsneuro@gmail.com  
 
Source of Monetary or Material Support  
Department of Neurology, Cardiothoracic and Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India, 110029 
 
Primary Sponsor  
Name  Dr Vaibhav Bhandari 
Address  Department of Neurology, Cardiothoracic and Neuroscience Centre, All India Institute of Medical Sciences, New Delhi 
Type of Sponsor  Other [self sponsership] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
dr vaibhav bhandari  All India Institute of Medical Sciences New Delhi  department of neurology, cardiothoracic and neuroscience centre,All India Institute of Medical Sciences New Delhi
South
DELHI 
9930265650

drvaibhavb96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institute ethics committee for post graduate research , all india institute of medical sciences, ansari nagar , new delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G409||Epilepsy, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Evidence based checklist   A tool used in wholesome care of epilepsy patient follow up. It will be used at the time of registering patient into trial. It will be used once only at the time of registering patient. Quality of life will be checked at baseline and after 1 year by QOLIE-31 scale. 
Comparator Agent  regular follow up in opd  There will be no tool/checklist used in this arm. Patient will be followed up similarly like intervention arm and quality of life will be assessed by QOLIE-31 at baseline and at the end of 1 year. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  a. People with epilepsy more than or equal to 18 years coming to neurology OPD, AIIMS, Delhi
b. Follow up more than 1 year in AIIMS OPD, all subtypes of epilepsy and seizure as defined by ILAE
c. Provide consent 
 
ExclusionCriteria 
Details  a. Less than 18 years of age
b. Refusal to consent
c. Newly diagnosed epilepsy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
assessment of change in quality of life by QOLIE-31 scale.  Assessment will be done at baseline, before using checklist and after 1 year of follow up. QOLIE 31 after 1 year will be compared from baseline as well as from control arm. 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of change in seizure frequency from baseline as well as comparison from control arm after using checklist.
• Assessment of change in seizure severity by National Hospital Seizure Severity Score (NHS3) from baseline as well as comparison from control arm after using checklist.
• Assessment of early identification & treatment of adverse drug reaction by subscale score of QOLIE-31
• Assessment of early identification of cognitive function by subscale score of QOLIE-31. 
all points mentioned above will be checked at baseline & after 1 year of follow up. 
 
Target Sample Size   Total Sample Size="108"
Sample Size from India="108" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In our study, we are going to use evidence-based checklist and outcome will be measured by 5 domains of COME-ILAE on follow up in a randomized control trial. This study will help in validation and observing outcome in form of improvement in quality of life primarily by use of evidence-based checklist. 
Close